The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

accrualPlot: Accrual Plots and Predictions for Clinical Trials

Tracking accrual in clinical trials is important for trial success. If accrual is too slow, the trial will take too long and be too expensive. If accrual is much faster than expected, time sensitive tasks such as the writing of statistical analysis plans might need to be rushed. 'accrualPlot' provides functions to aid the tracking of accrual and predict when a trial will reach it's intended sample size.

Version: 1.0.7
Depends: lubridate, R (≥ 2.10)
Imports: dplyr, ggplot2, grid, magrittr, purrr, rlang
Suggests: knitr, markdown, patchwork, rmarkdown, testthat, vdiffr
Published: 2022-08-16
DOI: 10.32614/CRAN.package.accrualPlot
Author: Lukas Bütikofer [cre, aut], Alan G. Haynes [aut]
Maintainer: Lukas Bütikofer <lukas.buetikofer at ctu.unibe.ch>
BugReports: https://github.com/CTU-Bern/accrualPlot/issues
License: MIT + file LICENSE
URL: https://github.com/CTU-Bern/accrualPlot, https://ctu-bern.github.io/accrualPlot/
NeedsCompilation: no
Materials: NEWS
In views: ClinicalTrials
CRAN checks: accrualPlot results

Documentation:

Reference manual: accrualPlot.pdf
Vignettes: accrualPlot

Downloads:

Package source: accrualPlot_1.0.7.tar.gz
Windows binaries: r-devel: accrualPlot_1.0.7.zip, r-release: accrualPlot_1.0.7.zip, r-oldrel: accrualPlot_1.0.7.zip
macOS binaries: r-release (arm64): accrualPlot_1.0.7.tgz, r-oldrel (arm64): accrualPlot_1.0.7.tgz, r-release (x86_64): accrualPlot_1.0.7.tgz, r-oldrel (x86_64): accrualPlot_1.0.7.tgz
Old sources: accrualPlot archive

Linking:

Please use the canonical form https://CRAN.R-project.org/package=accrualPlot to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.